ClassID:

21647

A61K2300/00 - page 87 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#25801
20050025840
2005-02-03

Compositions and methods directed towards sore muscles and joints

#25802
20050025839
2005-02-03

Formulation approach to enhance transporter-mediated drug uptake

#25803
20050025837
2005-02-03

Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin

#25804
20050025827
2005-02-03

Pharmaceutical formulation for contraception and hormone-replacement therapy

#25805
20050025823
2005-02-03

Methods of use of herbal compositions

#25806
20050025812
2005-02-03

Salad dressing with weight loss supplement

#25807
20050025807
2005-02-03

Cured porous calcium phosphate material and uses thereof

#25808
20050025805
2005-02-03

Osmium compounds for reduction of adverse inflammation

#25809
20050025804
2005-02-03

Reduction of adverse inflammation

#25810
20050025769
2005-02-03

Method of suppressing ongoing acute allograft rejection

#25811
20050025761
2005-02-03

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

#25812
20050025757
2005-02-03

Oxygen carrier system, artificial oxygen carrier, and reducing agent

#25813
20050025756
2005-02-03

Chemical combination and method for increasing delivery of Coenzyme Q10

#25814
20050025748
2005-02-03

Fixed-dried platelets cross-linked to protein

#25815
20050025744
2005-02-03

Combination therapies for multiple sclerosis

#25816
20050025737
2005-02-03

Compositions containing melon extracts

#25817
20050025734
2005-02-03

Inhibitors of proteasomal activity for stimulating hair growth

#25818
20050025723
2005-02-03

Sunburn treatment and sunburn prevention method

#25819
20050025722
2005-02-03

Removing dental plaque with krill enzymes

#25820
20050025719
2005-02-03

Method and apparatus for oral hygiene products with green tea extract

#25821
20050025718
2005-02-03

Medicaments for inhalation comprising an anticholinergic and a betamimetic

#25822
20050025716
2005-02-03

Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract

#25823
20050020915
2005-01-27

Myocardial perfusion imaging methods and compositions

#25824
20050020690
2005-01-27

Infiltration of capsaicin into surgical sites and open wounds

#25825
20050020682
2005-01-27

Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors

#25826
20050020671
2005-01-27

Pharmaceutical formulation

#25827
20050020668
2005-01-27

Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an HMG CoA reductase inhibitor

#25828
20050020666
2005-01-27

Cardioprotective agents

#25829
20050020657
2005-01-27

Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2

#25830
20050020656
2005-01-27

Organ fibrosis inhibitor

#25831
20050020647
2005-01-27

Compositions comprising epothilones and their use for the treatment of carcinoid syndrome

#25832
20050020641
2005-01-27

Therapeutic and diagnostic methods dependent on CYP2A enzymes

#25833
20050020639
2005-01-27

Compounds

#25834
20050020614
2005-01-27

Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof

#25835
20050020610
2005-01-27

Stable pharmaceutical composition of freeze-dried tetrodotoxin powder

#25836
20050020609
2005-01-27

Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes

#25837
20050020607
2005-01-27

Statin-MMP inhibitor combinations

#25838
20050020600
2005-01-27

Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists

#25839
20050020577
2005-01-27

Method of treating lower urinary tract disorders

#25840
20050020572
2005-01-27

Heterocyclic compounds as inhibitors of beta-lactamases

#25841
20050020571
2005-01-27

Combination of quetiapine and zolmitriptan

#25842
20050020567
2005-01-27

Method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent

#25843
20050020556
2005-01-27

Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes

#25844
20050020554
2005-01-27

Stability of hormone formulations

#25845
20050020552
2005-01-27

Pharmaceutical composition and method for transdermal drug delivery

#25846
20050020551
2005-01-27

Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application

#25847
20050020549
2005-01-27

Formulation containing anti-inflammatory androstane derivative

#25848
20050020548
2005-01-27

Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof

#25849
20050020538
2005-01-27

Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan

#25850
20050020535
2005-01-27

Konjac-mannan and ginseng compositions and methods and uses thereof

#25851
20050020534
2005-01-27

Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites

#25852
20050020528
2005-01-27

Chemokines with amino-terminal modifications

#25853
20050020517
2005-01-27

Treatment of HIV infection through combined administration of tipranavir and capravirine

#25854
20050020516
2005-01-27

Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors

#25855
20050020503
2005-01-27

Hepatitis C inhibitor compounds

#25856
20050020498
2005-01-27

Apo-2 ligand/trail formulations

#25857
20050020496
2005-01-27

Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment

#25858
20050020495
2005-01-27

Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors

#25859
20050020491
2005-01-27

Decorin proteoglycan inhibitor of fibrinogen blood clotting

#25860
20050020484
2005-01-27

Compositions for improving lipid metabolism

#25861
20050020482
2005-01-27

Methods for modulating gap junctions

#25862
20050019926
2005-01-27

Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same

#25863
20050019436
2005-01-27

Injectable capsaicin

#25864
20050019435
2005-01-27

Method of treating non-insulin dependent diabetes mellitus and related complications

#25865
20050019433
2005-01-27

Negatively charged polysaccharide derivable from aloe vera

#25866
20050019431
2005-01-27

Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof

#25867
20050019430
2005-01-27

Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil

#25868
20050019429
2005-01-27

Nutritional composition and method of inhibiting smooth muscle cell contraction thereof

#25869
20050019427
2005-01-27

Composition for stimulation of specific metallo-enzymes

#25870
20050019424
2005-01-27

Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives

#25871
20050019423
2005-01-27

Method for treating amyotrophic lateral sclerosis

#25872
20050019422
2005-01-27

Method and composition for treating acne

#25873
20050019417
2005-01-27

Method of preparing biological materials and preparations produced using same

#25874
20050019387
2005-01-27

Liposomal formulation of irinotecan

#25875
20050019386
2005-01-27

Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel

#25876
20050019343
2005-01-27

Prevention and treatment of amyloidogenic disease

#25877
20050019330
2005-01-27

Prevention and treatment of amyloidogenic disease

#25878
20050019328
2005-01-27

Prevention and treatment of amyloidogenic disease

#25879
20050019319
2005-01-27

Composition for mitigating a pernicious thrombotic event

#25880
20050019317
2005-01-27

Composition for human immunostimulation containing Lysozyme and Lactal Bumin

#25881
20050019305
2005-01-27

Methods of prevention and treatment of asthma, and allergic conditions

#25882
20050019271
2005-01-27

Treatment of respiratory diseases

#25883
20050019269
2005-01-27

Mold eradication with Thyme solution and other essential oils

#25884
20050015039
2005-01-20

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

#25885
20050014848
2005-01-20

Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors

#25886
20050014847
2005-01-20

Ambroxol for the treatment of chronic nociceptive pain

#25887
20050014846
2005-01-20

Ambroxol for the treatment of tinnitus

#25888
20050014845
2005-01-20

Ambroxol for the treatment of epilepsy

#25889
20050014844
2005-01-20

Ambroxol for the treatment of acute pain

#25890
20050014834
2005-01-20

Selective anesthetic agents and methods of identifying the same

#25891
20050014828
2005-01-20

Compositions containing prodrugs of florfenicol and methods of use

#25892
20050014827
2005-01-20

Synergistic medicament containing flavoring agents and having an antagonistic regenerative and/or protagonist decontamination effect

#25893
20050014819
2005-01-20

Peroxisome proliferator activated receptor ligand and process for producing the same

#25894
20050014808
2005-01-20

Combined agents for treatment of glaucoma

#25895
20050014799
2005-01-20

Pyridoxamine for the treatment of diabetic kidney disease

#25896
20050014797
2005-01-20

Compositions and methods to treat gastrointestinal disorders

#25897
20050014779
2005-01-20

Compositions and methods for treatment of neurological disorders

#25898
20050014770
2005-01-20

Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors

#25899
20050014743
2005-01-20

Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders

#25900
20050014738
2005-01-20

Method for obtaining estrogens from mare's urine

#25901
20050014734
2005-01-20

Modulation of interleukin-10 by DHEA

#25902
20050014733
2005-01-20

Therapeutic methods for muscular or neuromuscular disorders

#25903
20050014732
2005-01-20

Combination of an aldosterone receptor antagonist and an anti-diabetic agent

#25904
20050014730
2005-01-20

Anti-fungal formulation of triterpene and essential oil

#25905
20050014729
2005-01-20

Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith

#25906
20050014726
2005-01-20

Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol

#25907
20050014706
2005-01-20

Method of treating tuberculosis

#25908
20050014701
2005-01-20

Combination product comprising melagatran and dexamethasone

#25909
20050014699
2005-01-20

Combinations of enzyme inhibitor-containing preparations and the use thereof

#25910
20050014698
2005-01-20

Compositions for improved oxidative status in companion animals

#25911
20050014697
2005-01-20

Compositions and methods for modulating S-nitrosoglutathione reductase

#25912
20050014696
2005-01-20

Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone

#25913
20050014693
2005-01-20

Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia

#25914
20050014691
2005-01-20

Ophthalmic compositions comprising trefoil factor family peptides

#25915
20050014259
2005-01-20

Nucleic acid delivery

#25916
20050013921
2005-01-20

Novel multi-component garlic food supplement

#25917
20050013887
2005-01-20

Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors

#25918
20050013884
2005-01-20

Compositions and methods for treating heart disease

#25919
20050013881
2005-01-20

Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol

#25920
20050013880
2005-01-20

Anthocyanin-rich compositions and methods for inhibiting cancer cell growth

#25921
20050013875
2005-01-20

Immunopotentiators in thermotherapy for cancer

#25922
20050013874
2005-01-20

Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticles and therapeutic agent for treating zinc deficiency

#25923
20050013871
2005-01-20

Pharmaceutical composition for the treatment of itch

#25924
20050013863
2005-01-20

Dual drug dosage forms with improved separation of drugs

#25925
20050013853
2005-01-20

Anti-proliferative drugs

#25926
20050013849
2005-01-20

Pet food composition for regulating body weight and preventing obesity and related disorders in pets

#25927
20050013815
2005-01-20

Prevention and treatment of amyloidogenic disease

#25928
20050013801
2005-01-20

Methods of treating liver fibrosis and hepatitis c virus infection

#25929
20050013800
2005-01-20

Methods of prevention and treatment of asthama, and allergic conditions

#25930
20050013799
2005-01-20

Methods of prevention and treatment of asthma, and allergic conditions

#25931
20050013794
2005-01-20

Antimicrobial polymeric biguanide and acidic co-polymer composition and method of use

#25932
20050013783
2005-01-20

Method of skin care using lipoic and ascorbic acids

#25933
20050010040
2005-01-13

Compositions enriched in phenolic compounds and methods for producing the same

#25934
20050009927
2005-01-13

Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors

#25935
20050009925
2005-01-13

Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure

#25936
20050009916
2005-01-13

Treatment of central neuropathic pain

#25937
20050009904
2005-01-13

Composition and method for prevention and treatment of arrhythmias

#25938
20050009899
2005-01-13

Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

#25939
20050009896
2005-01-13

Drugs comprising combination of antithrombotic agent with pyrazolone derivative

#25940
20050009891
2005-01-13

Combination of SRC Kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases

#25941
20050009888
2005-01-13

Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release

#25942
20050009868
2005-01-13

Retinoid receptor pan-antagonists for stimulating chondrogenesis

#25943
20050009861
2005-01-13

Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders

#25944
20050009835
2005-01-13

Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors

#25945
20050009814
2005-01-13

Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist

#25946
20050009810
2005-01-13

Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors

#25947
20050009798
2005-01-13

Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists

#25948
20050009795
2005-01-13

Mixtures or organic compounds for the treatment of airway diseases

#25949
20050009793
2005-01-13

Treatment of liver disease with active vitamin D compounds

#25950
20050009790
2005-01-13

Ear and wound treatment

#25951
20050009782
2005-01-13

Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof

#25952
20050009781
2005-01-13

Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents

#25953
20050009779
2005-01-13

Preparation for improving the action of receptors

#25954
20050009773
2005-01-13

Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents

#25955
20050009762
2005-01-13

Application of water and organic solvent soluble ivermectin for topical and oral use

#25956
20050009754
2005-01-13

Use of growth hormone secretagogues for treatment of fibromyalgia

#25957
20050009747
2005-01-13

High purity lipopeptides

#25958
20050009744
2005-01-13

Treatment of congestive heart failure

#25959
20050009739
2005-01-13

Formulation strategies in stabilizing peptides in organic solvents and in dried states

#25960
20050009736
2005-01-13

Methods and compositions for optimization of oxygen transport by cell-free systems

#25961
20050009733
2005-01-13

Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage

#25962
20050009150
2005-01-13

Humanized antibodies that recognize beta amyloid peptide

#25963
20050008746
2005-01-13

Colorant for food and pharmaceuticals

#25964
20050008726
2005-01-13

Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors

#25965
20050008725
2005-01-13

Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors

#25966
20050008724
2005-01-13

Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors

#25967
20050008723
2005-01-13

Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors

#25968
20050008722
2005-01-13

Compositions incorporating(-)-hydroxycitric acid and related methods for promoting fat oxidation

#25969
20050008721
2005-01-13

Anti-depression pharmaceutical composition containing extract

#25970
20050008720
2005-01-13

Anti-depression pharmaceutical composition containing extract

#25971
20050008719
2005-01-13

Anti-depression pharmaceutical composition containing Polygala extract

#25972
20050008717
2005-01-13

Anti-neoplastic compositions comprising extracts of black cohosh

#25973
20050008716
2005-01-13

Synergistic composition for the treatment of diabetes mellitus

#25974
20050008713
2005-01-13

Compositions of plant carbohydrates as dietary supplements

#25975
20050008711
2005-01-13

Oral compositions for the treatment of scalp disorders

#25976
20050008707
2005-01-13

Nanoparticulate megestrol formulations

#25977
20050008699
2005-01-13

Effervescent glucosamine composition

#25978
20050008695
2005-01-13

Compositions and methods for delivering a biologically active agent

#25979
20050008679
2005-01-13

Nutritional product for enhancing growth and/or strengthening the immune system of equine foals

#25980
20050008678
2005-01-13

Food compositions containing creatine

#25981
20050008665
2005-01-13

Cosmetic or dermatological active ingredient combination

#25982
20050008656
2005-01-13

Compositions and methods for an orally administered inhibitor of biting insects

#25983
20050008641
2005-01-13

Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins

#25984
20050008633
2005-01-13

Chemical and physical modulators of bioavailability of inhaled compositions

#25985
20050008632
2005-01-13

Carrier with solid fibrinogen and solid thrombin

#25986
20050008590
2005-01-13

Effective method for regulating the appearance of skin

#25987
20050008587
2005-01-13

Cosmetic and dermatological photoprotective formulations with a content of hydroxybenzophenones, triazine derivatives and/or benzotriazole derivatives

#25988
20050008581
2005-01-13

Methods and compositions that enhance bioavailability of coenzyme-Q10

#25989
20050008535
2005-01-13

Noble gas-chlorine mixture effective against micro organisms

#25990
20050004663
2005-01-06

Heparin barrier coating for controlled drug release

#25991
20050004228
2005-01-06

Long-acting drug combinations for the treatment of respiratory complaints

#25992
20050004225
2005-01-06

Oxidoreductase inhibitors and methods of screening and using thereof

#25993
20050004224
2005-01-06

Treatment of Alzheimer's disease with the R(-) isomer of a 2-arylpropionic acid non-steroidal anti-inflammatory drug alone or in combination with a cyclooxygenase-2 selective inhibitor

#25994
20050004222
2005-01-06

Methods for prevention and treatment of gastrointestinal disorders

#25995
20050004199
2005-01-06

Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist

#25996
20050004194
2005-01-06

Use of organic compounds

#25997
20050004184
2005-01-06

Thyroid receptor ligands

#25998
20050004181
2005-01-06

Use of anti-emetic for pre and post operative care

#25999
20050004177
2005-01-06

Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor

#26000
20050004171
2005-01-06

Novel substituted benzimidazole dosage forms and method of using same

#26001
20050004155
2005-01-06

Use of methylnaltrexone to treat irritable bowel syndrome

#26002
20050004145
2005-01-06

Method of improved diuresis in individuals with impaired renal function

#26003
20050004144
2005-01-06

Combined use of IMPDH inhibitors with toll-like receptor agonists

#26004
20050004124
2005-01-06

THERAPIES RELATING TO COMBINATIONS OF ALDOSE REDUCTASE INHIBITORS AND CYCLOOXYGENASE-2 INHIBITORS

#26005
20050004108
2005-01-06

Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration

#26006
20050004107
2005-01-06

Telmisartan sodium salt pharmaceutical formulation

#26007
20050004106
2005-01-06

Combinations of GABA modulators and anticonvulsants, and atypical antipsychotics

#26008
20050004090
2005-01-06

Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors

#26009
20050004088
2005-01-06

Hormonal contraceptive product

#26010
20050004084
2005-01-06

Aspirin-containing trasdermal pharmaceutical composition for the treatment of calcification

#26011
20050004081
2005-01-06

Pharmaceutical combinations for the treatment of cancer

#26012
20050004076
2005-01-06

Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof

#26013
20050004055
2005-01-06

Increasing electro-gene transfer of nucleic acid molecules into host tissue

#26014
20050004051
2005-01-06

Methods for treatment of bacterial infections in impaired renal patients

#26015
20050004050
2005-01-06

Dalbavancin compositions for treatment of bacterial infections

#26016
20050004046
2005-01-06

Method for increasing cognitive function and neurogenesis

#26017
20050004030
2005-01-06

Phage-associated lytic enzymes for treatment of and related conditions

#26018
20050004029
2005-01-06

Methods and compositions for treating vascular leak using hepatocyte growth factor

#26019
20050004027
2005-01-06

Method of treating corneal transplant rejection

#26020
20050004023
2005-01-06

Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment

#26021
20050004018
2005-01-06

Use of antitumoral compound in cancer therapy

#26022
20050004011
2005-01-06

Compositions and methods for treating bacterial infections with protein-dalbavancin complexes

#26023
20050004007
2005-01-06

Promotion of adoptosis in cancer cells by co-administration of cyclin dependent kinase inhibitiors and cellular differentiation agents

#26024
20050004004
2005-01-06

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#26025
20050004002
2005-01-06

Compositions and methods of delivery of pharmacological agents

#26026
20050003976
2005-01-06

Sympathetic nerve-stimulating fragrant compositions

#26027
20050003510
2005-01-06

Surface expression of biologically active proteins in bacteria

#26028
20050003465
2005-01-06

PSCA: prostate stem cell antigen and uses thereof

#26029
20050003031
2005-01-06

Anti-cancer compounds

#26030
20050003029
2005-01-06

UTILIZATION OF RUTINS AND AESCINS IN THE TREATMENT OF OCULAR CIRCULATORY DISTURBANCES

#26031
20050003028
2005-01-06

Composition for protection and regeneration of structure and function of the liver

#26032
20050003027
2005-01-06

Chemical composition and method to bind fat, enhance metabolization, and aid digestion

#26033
20050003024
2005-01-06

Regulation of mammalian hair growth

#26034
20050003023
2005-01-06

Topical composition for the treatment of psoriasis and related skin disorders

#26035
20050003021
2005-01-06

Bowel cleansing agent

#26036
20050003020
2005-01-06

Anti-viral compositions and methods of making and using the anti-viral compositions

#26037
20050003009
2005-01-06

Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients

#26038
20050003003
2005-01-06

Modulation of release from dry powder formulations

#26039
20050003002
2005-01-06

Sustained-release, oral pharmaceutical formulations and methods of making and using same

#26040
20050002992
2005-01-06

Foods, beverages, condiments, spices and salad dressings with specialized supplements

#26041
20050002988
2005-01-06

Nutritional composition for controlling blood sugar level

#26042
20050002986
2005-01-06

Drug/drug delivery systems for the prevention and treatment of vascular disease

#26043
20050002979
2005-01-06

Method of treating actinic keratosis

#26044
20050002962
2005-01-06

Immunostimulatory agents in botanicals

#26045
20050002961
2005-01-06

Concentrate comprising green tea, grape skin extract and grape extract, the production thereof and use of the same

#26046
20050002941
2005-01-06

Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

#26047
20050002935
2005-01-06

Use of B7-H3 as an immunoregulatory agent

#26048
20050002933
2005-01-06

Methods for modulating hematopoiesis and vascular growth

#26049
20050002928
2005-01-06

Treatment with anti-ErbB2 antibodies

#26050
20050002921
2005-01-06

Lactic acid bacteria and its use in direct-fed microbials

#26051
20050002916
2005-01-06

Cytokine-expressing cellular vaccine combinations

#26052
20050002904
2005-01-06

Uses of vascular endothelial growth factor and type I collagen inducible protein (VCIP)

#26053
20050002901
2005-01-06

Compositions and methods for treating coronavirus infection and SARS

#26054
20050002900
2005-01-06

Method of treating estrogen responsive breast cancer

#26055
20050002899
2005-01-06

Method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture

#26056
20050002896
2005-01-06

Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture

#26057
20050002879
2005-01-06

External skin compositions

#26058
20050002877
2005-01-06

One and only toe nail/finger nail fungus killer

#26059
16362899
2020-02-04

Method for treating cannabis induced anxiety

#26060
16153342
2020-08-18

Micro-RNA profiling, compositions, and methods of treating diseases

#26061
16130836
2019-11-26

Salts of cycloserine compounds and applications thereof

#26062
16124957
2020-08-11

Methods for treating pain associated with sickle cell disease

#26063
16118349
2019-07-16

Therapy and prevention of prion protein complex infections

#26064
16101828
2019-04-23

Antibiotic solution and method of injection to prevent ophthalmic infections

#26065
16020478
2019-07-02

Device for titrating basal insulin

#26066
16005052
2021-01-12

Methods and compositions for treating cancer

#26067
15996034
2019-05-07

Method for treating cannabis induced anxiety

#26068
15990049
2020-05-12

5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents

#26069
15973438
2019-10-01

Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues

#26070
15967034
2024-01-09

Post-transplantation prophylaxis and treatments for antibody-mediated rejection of solid organ transplant

#26071
15965473
2022-04-12

Topical skin health improvement compositions and administrations thereof

#26072
15853748
2019-04-16

Vaporizable cannabinoid compositions

#26073
15814105
2018-04-10

Macrocyclic compound and uses thereof

#26074
15699789
2020-11-10

Homeopathic formulations

#26075
15681716
2018-06-05

Process for synthesis of Eliglustat and intermediate compounds thereof

#26076
15622238
2018-04-17

Biocompatible dental putty formulations for controlled release of bupivacaine

#26077
15621298
2018-05-29

Extended release methazolamide formulation

#26078
15607825
2018-06-26

Solid dispersion formulation

#26079
14702059
2020-09-15

Modulation of T cell signaling via slat association with IP3R1

#26080
13374856
2014-09-16

Deodorizing and skin cleaning

#26081
12931761
2014-08-26

System to verify identity of patient receiving medication and monitoring the dispensing of medication to the patient including monitoring the development of the medication form where the seeds are obtained, how the plant was cultivated, where the medical portion of the plant was harvested and converted into the medication to be dispensed to a patient

#26082
10163657
2014-11-18

Methods of administering anti-TNFα antibodies